Peripheral artery disease (PAD) is an exceedingly common disease attributed to multiple risk factors, most of which are modifiable. Clinical decisions regarding treatment options are dependent on the distribution and severity of PAD and the patient’s clinical presentation. This chapter is dedicated to discussing the diagnosis and management of atherosclerotic disease distal to the inguinal ligament. The approach to infrainguinal PAD treatment is multidisciplinary, with interventional radiology (IR) playing a pivotal role. It is from treating PAD that the field of IR was born, when in 1964 Dr. Charles Dotter successfully treated a woman’s non-healing foot ulcer with balloon angioplasty of an upstream arterial stenosis.
KeywordsPeripheral artery disease (PAD) Angioplasty Stent Atherosclerosis Critical limb ischemia Claudication Acute limb ischemia Subintimal arterial flossing with antegrade-retrograde intervention (SAFARI)
- 8.Stary HC, Blankenhron DH, Chandler AB, Glagov S, Insull W, Richardson M. A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1992;85(1):391–405.CrossRefPubMedGoogle Scholar
- 13.Kaufman JA, Lee MJ. The requisites: vascular and interventional radiology. 2nd ed. Philadelphia: Elsevier; 2014.Google Scholar
- 14.Geschwind JH, Dake MD. Abrams’ angiography: interventional radiology. 2nd ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins Health; 2014.Google Scholar
- 20.Kandarpa K, Machan L. Handbook of interventional radiologic procedures. 4th ed: Lippincott Williams & Wilkins; Philadelphia 2011.Google Scholar
- 25.Scheinert D, Duda S, Zeller T, Krankenberg H, Ricke J, Bosiers M. The LEVANT 1 (Lutonix paclitaxel-coated balloon for the prevention of remoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. JACC Cardiovasc Interv. 2014;7(1):10–9.CrossRefPubMedGoogle Scholar
- 26.Center for Devices and Radiological Health. Recently-Approved Devices - Endurant II/Endurant IIs Stent Graft System-P100021/S063 [Internet]. U S Food and Drug Administration Home Page. Center for Devices and Radiological Health; [cited 2018Mar23]. Available from: https://www.fda.gov/medicaldevices/productsandmedicalprocedures/deviceapprovalsandclearances/recentlyapproveddevices/ucm581234.htm.